Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Merseyside and Cheshire Cancer Network - why we are here and what’s next! Linda Devereux Associate Director Challenge of cancer – national context • Major cause of concern to the public • Every year over 200,000 people in England will be diagnosed with cancer • Cancer is the biggest killer with 125,000 people dying each year • Many more people are now living with cancer National priorities Need to address variation in life expectancy Need to reduce deaths from cancer Need for investment to improve survival rates Need to improve access and end the ‘postcode lottery’ National Policy - 2000 Improving • Prevention • Screening • Cancer services in the community • Treatment and care Cutting waiting times Investing in staff and facilities Future plans – research and genetics Cancer Patient pathway Primary Care General Practitioner Secondary Care District General Hospital Specialist Treatment Centre Tertiary Care Aftercare and Support Cancer Networks – The Benefits • Opportunity to collaborate and share best practice • Improved communication and standardisation • Ensuring patients have the equal access to the best possible care and treatment across the network • Coordinated across a patient pathways rather than formal organisational boundaries • Opportunities for patient and user involvement • 12 Hospital Trusts • 7 Primary Care Trusts • plus Isle of Man and parts of North Wales • 2.3 m population • Established in 2000 New cases of cancer - MCCN New cases of cancer within Merseyside and Cheshire Network (2006) Data source: National Cancer Intelligence Service Brain/CNS (161) Gynaecological (563) Head & Neck (423) Lung (1690) Other (406) Upper GI (1082) Breast (1733) Haematological (792) Lower GI (1286) Malignant Melanoma (366) Sarcoma (82) Urological (1912) Challenge of cancer – Merseyside and Cheshire • Over 10,000 new cases diagnosed every year • For the biggest single group – lung cancer – our rates are 18% higher that the national average • Death rates are also higher – 5,500 people die each year from cancer. • We have the worst mortality rates in the country – 21% higher than England Partnership working Network Board Lead Clinicians Lead Nurses and AHPs Development and Implementation of Cancer Strategy Clinical Network Groups X 26 Network Managers Localities X5 Transformation of services • • • • • • Multi-disciplinary teams formed to manage every cancer patient Clinical expertise concentrated into specialist teams Better treatment – surgery, radiotherapy, chemotherapy Challenging waiting times targets achieved Development of screening programmes Emphasis on addressing health inequalities that exist through earlier detection and prevention • Significant contribution made by patients, carers, volunteers and staff Contrasting pathways - then and now.. Cancer Reform Strategy – challenges and opportunities • • • • • • Incidence of cancer is increasing as people live longer More people are alive having survived cancer Scientific understanding is improving greatly New opportunities for early diagnosis New treatments in the pipeline Potential to introduce new service models to improve convenience and outcomes for patients Building for the future • Bringing services closer to patients’ homes • New models of services eg changing inpatient management • Development of a comprehensive cancer centre • Increasing incidence but new targetted therapies • New technologies • Needs of patients surviving their cancer and living longer • Patient involvement critical as we deal with these challenges Building for the future New cases of cancer set to rise • Ageing population, obesity More people will survive and live longer • Need for different kinds of support and care Better knowledge of how to prevent, diagnose and treat cancer • Advances in medical technology Need for greater effectiveness and efficiency Patient and public involvement is critical